Gaudium IVF, a leader in India’s fertility healthcare sector, has launched groundbreaking AI-driven infertility treatments, solidifying its innovation leadership after becoming India’s first publicly listed IVF chain. The initiative incorporates two advanced AI technologies: the Sperm Identification Device (SiD) and the Embryo Ranking Intelligent Classification Assistant (ERICA), enhancing precision in sperm selection and embryo ranking. Inaugurated by Union Minister Nitin Gadkari, this development emphasizes the role of technology in healthcare advancements. Gaudium IVF has collaborated with UK-based IVF 2.0 to incorporate these global embryology innovations into the Indian fertility landscape. Dr. Manika Khanna, the company’s Managing Director, stated that AI integration will foster greater transparency and improve success rates in IVF treatments. Initial clinical observations suggest that these AI tools can significantly enhance fertilization outcomes and reduce the emotional and financial burdens associated with multiple IVF cycles. Overall, this advancement aims to transform fertility care through personalized and effective technologies.
Source link
Share
Read more